Israeli Study Links GLP-1 Drugs to Rare Brain Disorder

Israeli Study Links GLP-1 Drugs to Rare Brain Disorder

Santé
Connectez-vous pour épingler cet événement

Israeli researchers identified 15 cases of Wernicke encephalopathy among users of GLP-1 weight-loss drugs in Israel, prompting calls for further investigation. Earlier reports noted that the study, which examined nearly 196,000 patients, found the cases were disproportionately linked to semaglutide and tirzepatide, highlighting a risk of severe vitamin-B1 deficiency.

Acteurs

Israeli researchers semaglutide tirzepatide

Lieux

Israel

Vérification des faits

Comment fonctionnent ces métriques
Verdict global: Preuves insuffisantes Confiance: 22%
Résumé

All three claims stating that researchers or reviews identified 15 cases of Wernicke encephalopathy associated with GLP-1 receptor agonists, including semaglutide and tirzepatide, between September 11 and 13, 2026, have insufficient evidence.

Connectez-vous ou abonnez-vous pour voir l'analyse complète avec les affirmations, les sources et la validation chronologique.

Créer un compte Se connecter

Cette section contient une vérification automatisée des affirmations à partir de sources externes et peut contenir des inexactitudes.

Articles

15 septembre 2026
1 au total
Study reveals possible link between GLP-1 weight loss drugs and rare brain condition
Study reveals possible link between GLP-1 weight loss drugs and rare brain condition

The Independent • 15 sept. 17h45

An Israeli review of FDA adverse-event reports identified 15 instances of Wernicke encephalopathy among users of GLP-1 medications, prompting calls for further investigation.

Crédibilité 71% Manip. 9% Centre
13 septembre 2026
2 au total
Ozempic and Wegovy may cause rare brain disorder, new study warns
Ozempic and Wegovy may cause rare brain disorder, new study warns

Fox News • 13 sept. 17h00

A review of FDA reports and medical literature identified 15 cases of Wernicke encephalopathy among users of semaglutide and tirzepatide, prompting calls for further research.

Crédibilité 68% Manip. 30% Centre
Popular GLP-1 weight-loss drugs linked to potentially deadly brain disorder
Popular GLP-1 weight-loss drugs linked to potentially deadly brain disorder

Yahoo Health • 13 sept. 17h00

Researchers identified 15 reports of Wernicke encephalopathy in patients using GLP-1 receptor agonists, highlighting a possible link to vitamin B1 deficiency but noting the rarity of the condition.

Crédibilité 68% Manip. 12% Centre
12 septembre 2026
1 au total
GLP-1-driven vitamin deficiency linked to rare brain disorder: Study
GLP-1-driven vitamin deficiency linked to rare brain disorder: Study

NewsNation • 12 sept. 20h18

Researchers identified 15 cases of Wernicke encephalopathy in 2023-2024 among patients using GLP-1 agonists, highlighting a potential risk of severe thiamine deficiency.

Crédibilité 72% Manip. 8% Centre
11 septembre 2026
1 au total
2 popular GLP-1 drugs linked to rare, life-threatening brain disorder
2 popular GLP-1 drugs linked to rare, life-threatening brain disorder

New York Post • 11 sept. 16h09

Research involving nearly 196,000 patients identified 15 cases of Wernicke encephalopathy, a serious condition linked to vitamin B1 deficiency, that were disproportionately associated with semaglutide and tirzepatide.

Crédibilité 57% Manip. 27% Centre

Événements liés